← Back to graph
Microorganism

Lactobacillus johnsonii

Selected indexed studies

  • Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206(+) macrophages(IL-10) activation. (Gut Microbes, 2022) [PMID:36398889]
  • Targeting Lactobacillus johnsonii to reverse chronic kidney disease. (Signal Transduct Target Ther, 2024) [PMID:39098923]
  • Bacteroides uniformis degrades β-glucan to promote Lactobacillus johnsonii improving indole-3-lactic acid levels in alleviating colitis. (Microbiome, 2024) [PMID:39300532]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

Local graph